WuXi AppTec
WuXi AppTec is a global CRDMO offering integrated R&D and manufacturing services for the pharmaceutical and life sciences industries. They partner with over 6,000 companies worldwide to accelerate the development of breakthrough treatments.
WuXi AppTec is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) dedicated to advancing healthcare innovation. With extensive operations across Asia, Europe, and North America, they provide comprehensive, end-to-end R&D and manufacturing services to pharmaceutical and life sciences partners. They collaborate with nearly 6,000 partners in over 30 countries, supporting their efforts to bring novel treatments to patients. WuXi AppTec's vision is to ensure that every drug can be made and every disease can be treated, driving progress through collaboration and innovative solutions. Their services are crucial for companies seeking to develop and manufacture new therapies. WuXi AppTec's commitment to quality and innovation is demonstrated by their successful FDA inspections and recognition in industry awards, solidifying their position as a trusted partner in the global healthcare ecosystem.
About
**Who they are**
WuXi AppTec is a global CRDMO that provides integrated R&D and manufacturing services for the pharmaceutical and life sciences industries. They partner with over 6,000 companies worldwide to accelerate the development of breakthrough treatments.
**Expertise & scope**
* Offers comprehensive CRDMO services for global pharmaceutical development.
* Provides integrated, end-to-end services through a unique CRDMO platform.
* Supports partners in bringing breakthrough treatments to patients.
* Collaborates to deliver comprehensive capabilities and innovative technologies in the pharmaceutical and healthcare industry.
**Reputation / proof points**
* Works with nearly 6,000 partners across 30+ countries.
* Operations across Asia, Europe, and North America.
WuXi AppTec is a global CRDMO that provides integrated R&D and manufacturing services for the pharmaceutical and life sciences industries. They partner with over 6,000 companies worldwide to accelerate the development of breakthrough treatments.
**Expertise & scope**
* Offers comprehensive CRDMO services for global pharmaceutical development.
* Provides integrated, end-to-end services through a unique CRDMO platform.
* Supports partners in bringing breakthrough treatments to patients.
* Collaborates to deliver comprehensive capabilities and innovative technologies in the pharmaceutical and healthcare industry.
**Reputation / proof points**
* Works with nearly 6,000 partners across 30+ countries.
* Operations across Asia, Europe, and North America.
Additional information
WuXi AppTec's services are designed to support the entire lifecycle of pharmaceutical and life sciences product development. Their integrated platform aims to streamline the R&D and manufacturing processes, enabling partners to bring innovative treatments to market more efficiently. The company emphasizes collaboration and aims to advance healthcare innovation by supporting customers in delivering groundbreaking treatments globally.
Key Highlights
-
WuXi AppTec is a global CRDMO offering integrated R&D and manufacturing services.
Source
“WuXi AppTec is a global CRDMO offering integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.”
-
Partners with over 6,000 companies worldwide.
Source
“We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients.”
-
Provides integrated, end-to-end services through a unique CRDMO platform.
Source
“With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform.”
Certifications & Trust Signals
-
Operations across Asia, Europe, and North America.
Source
“With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform.”
Buyer Snapshot
Best for
- Companies seeking integrated R&D and manufacturing services.
- Pharmaceutical and life sciences organizations.
How engagement typically works
- Collaborative partnerships.
- End-to-end service provision.
Typical deliverables
- Accelerated drug development.
- Breakthrough treatment advancements.
- Integrated R&D and manufacturing solutions.
Good to know
- Best when seeking a global CRDMO partner.
HQ:
Shanghai, China
Languages:
English
Timezones:
UTC+8
Status:
listed
Services & Capabilities
Biocompatibility Testing (ISO 10993 Program)
Countries:
United States, United Kingdom, Switzerland, China, Singapore, Denmark, Europe, Asia
Industries:
Medical Devices
Iso10993 Standards Supported:
ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 10993-11, ISO 10993-12, ISO 10993-18, USP <87>, USP <88>
Test Types Offered:
Cytotoxicity, Sensitization, Irritation, Systemic toxicity, Hemocompatibility, Pyrogenicity, Biodegradation
Glp Compliant:
Yes
Has In House Toxicology:
Yes
Contact Types Supported:
Surface contact, External communicating, Implant
Duration Types Supported:
Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Regions Served:
Asia, Europe, North America
Rush Available:
Yes
Nda Support:
Yes
sterilization_microbiology_testing
Additional biocompatibility_testing Details
Iso10993 Standards Supported
ISO 10993
Test Types Offered
Biocompatibility Testing
